Previous Page  2 / 14 Next Page
Information
Show Menu
Previous Page 2 / 14 Next Page
Page Background

Notes:

Page 34

March 25-26, 2019 | Amsterdam, Netherlands

2

nd

Global Public Health Congress

Journal of Community Medicine & Health Education | ISSN : 2161-0711

Volume 09

Global Public Health 2019

Early age drug injection initiation as risk factor for HIV/HCV

coinfection among drug users in rural communities of Puerto Rico

T

his study aimed to estimate the prevalence of HIV/HCV coinfection and its association

with drug injection initiation at an early age among drug users residing in the rural

communities of Puerto Rico. With the utilization of a response driven sampling method,

315 intravenous drug users were recruited. Information on sociodemographics, drug

use patterns, age of drug injection initiation, and risk behaviors were obtained through

structured interviews. HIV and HCV status were determined by the results of the INSTI

Rapid HIV and OraQuick Rapid HCV tests. Frequency distributions, bivariate analyses

and multinomial logistic regression were used to assess covariates of HIV/HCV. The study

received IRB approval through the University of Nebraska-Lincoln and the University of

Puerto Rico. Approximately 91% of study participants were males. Participants’ mean

age was 41.7 years and the majority had not completed high school (47.6%). More than

three quarters (78.4%) tested positive for HCV during the rapid test, while 6.0% tested

positive for HIV. The prevalence of HIV/HCV coinfection was 6.0%. The mean age of

drug injection initiation was 21.9 years. HIV/HCV coinfection was strongly associated

with drug injection initiation at an early age. The odds of IDUs who initiated drug

injection before 18 years was 3 times the odds of IDUs who commenced drug injection

after 18 years age (OR=3.8 95%; CI=1.3, 11.3). Strengthening policies and effective harm

reduction interventions that prevent early drug injection initiation may reduce HIV/HCV

coinfection among drug users in rural communities in Puerto Rico.

Biography

Juan Carlos Reyes-Pulliza received his EdD from the University of Puerto Rico, Río Piedras Campus in 2003.

He is a Research Associate in the Center for Addiction Studies of the Universidad Central del Caribe. He is

currently a Professor and Director of the Department of Biostatistics and Epidemiology in the University of

Puerto Rico. He has published over 25 journal articles and chapters in the areas of Epidemiology of Drug

Abuse, Mental Health and HIV risk behaviors. Currently, he is working as Co-investigator on several NIH-

funded grants in Puerto Rico.

juan.reyes5@upr.edu

Juan Carlos Reyes-Pulliza, J Community Med Health Educ 2019, Volume 09

DOI: 10.4172/2161-0711-C2-057

Juan Carlos Reyes-Pulliza

University of Puerto Rico, Medical Sciences

Campus, Puerto Rico